Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF ISIN · CA74319B5027 US Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country US United States of America
Listing US PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets incision-free therapies for ablative interventions. The company's primary platform, TULSA-PRO®, combines real-time Magnetic Resonance (MR) imaging with robotically-driven, transurethral thermal ultrasound and closed-loop temperature feedback. This system is designed for the precise and customizable ablation of prostate tissue from the inside-out. It is used to treat various conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). The technology enables physicians to create customized treatment plans and monitor tissue temperature in real-time, aiming to maximize efficacy while preserving patient quality of life.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings
2026-05-15 English
FORM 8-K
Regulatory Filings
2026-05-14 English
S-3 - Profound Medical Corp. (0001628808) (Filer)
Regulatory Filings
2026-05-12 English
10-Q - Profound Medical Corp. (0001628808) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-07 English
8-K - Profound Medical Corp. (0001628808) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text indicates it announces the planned release date of the company's first quarter 2026 financial results and a conference call to discuss those results. It includes a press release as an exhibit but does not contain the actual financial results or detailed financial data itself. The document is relatively short (4174 characters) and serves as an announcement of an upcoming earnings release and conference call, not the earnings release itself. Therefore, it fits the category of a Regulatory Filing (RNS) rather than an Earnings Release (ER) or Interim Report (IR).
2026-04-16 English
8-K - Profound Medical Corp. (0001628808) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated April 14, 2026. It announces that the company will present an update at an investor conference and includes a press release as an exhibit. The document is relatively short (4060 characters) and primarily serves as a disclosure of an event rather than containing detailed financial data or a full report. It does not contain financial statements or substantive financial analysis. The nature of the filing is an event-driven disclosure rather than a full financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2026-04-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.